The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats
- 19 May 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Atherosclerosis Reports
- Vol. 20 (6), 31
- https://doi.org/10.1007/s11883-018-0731-0
Abstract
We summarize recent advances in the understanding of genetic testing in familial hypercholesterolemia (FH), the use of expanded FH next-generation sequencing panels, and directions for future research.This publication has 42 references indexed in Scilit:
- Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 CountriesClinical Chemistry, 2015
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationInternational Journal of Cardiology, 2014
- APOE p.Leu167del mutation in familial hypercholesterolemiaAtherosclerosis, 2013
- Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemiaMolecular Genetics & Genomic Medicine, 2013
- Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control studyThe Lancet, 2013
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del MutationHuman Mutation, 2012
- Genetic analysis of familial hypercholesterolaemia in Western AustraliaAtherosclerosis, 2012
- Familial hypercholesterolaemia: A model of care for AustralasiaAtherosclerosis Supplements, 2011
- Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemiaHuman Mutation, 2010
- Revisting wilson and Jungner in the genomic age: a review of screening criteria over the past 40 yearsBulletin of the World Health Organization, 2008